AIQ Momentum Leaders

The current leaderboard structure shows a high concentration in the Technology sector, which accounts for 14 of the ranked names. While Technology provides the broadest base of participation, the top five positions are more distributed across the Consumer Cyclical and Healthcare sectors. This distribution indicates that while technology is a primary component of the cohort, specific momentum signals are currently prominent in consumer-facing and healthcare segments.

At the top of the rankings, EXPE holds the first position with an AIQ Score of 65.0. Its profile is supported by a momentum score of 95.0 and a risk score of 45.0. Following closely, ULTA occupies rank 2 with an AIQ Score of 66.0, also supported by a momentum score of 93.0. These top positions are characterized by high momentum scores exceeding 90, which serves as the primary driver for their current placement in this momentum-focused cohort.

Significant movement is observed in the Healthcare sector, where REGN entered the leaderboard at rank 4 with an AIQ Score of 68.0. This entry is supported by a momentum delta of 57.0 and a momentum score of 91.0. The inclusion of both ELV and REGN in the top five indicates concentrated strength in healthcare names that possess strong momentum profiles. These entries provide a counterweight to the broader technology concentration seen further down the rankings.

The Financial Services sector also shows notable activity, with ALL holding rank 5 at an AIQ Score of 76.0 and BRK.B at rank 7 with an AIQ Score of 85.0. While these names possess high AIQ Scores, their profiles differ significantly; ALL is supported by a quality score of 86.0, while BRK.B's profile is characterized by a higher risk score of 79.0. These differences show that the top ranks are not uniform in their underlying factor compositions despite their shared presence in the momentum-focused list.

Rank movements provide further evidence of shifting dynamics. HIG moved up significantly, jumping from rank 50 to rank 22, supported by a momentum delta of 27.0 and an AIQ Score of 72.0. Similarly, ACGL improved its position from rank 40 to 24. These upward moves are primarily driven by gains in the momentum component of their respective profiles. Conversely, COST experienced a significant decline, falling from rank 1 to rank 32, despite maintaining a high momentum score of 95.0, suggesting that other factors in its profile may have weakened relative to the cohort.

The list of entrants and exits highlights specific changes in the available evidence pool. New entries include EXPE, REGN, ADBE, PGR, UHS, and ROP. These additions bring a variety of factor profiles into the mix, such as ADBE's quality score of 91.0 and ROP's momentum score of 95.0. Meanwhile, several names exited the cohort, including V, ABNB, AMT, IT, MNST, and DOCS. The exit of these names, particularly those in the Technology and Consumer Cyclical sectors, alters the concentration profile of the remaining ranked items.

A notable observation is the divergence in momentum quality among top-ranked names. While EXPE and ROP both possess high momentum scores of 95.0, their AIQ Scores differ by 4 points. This suggests that while momentum is a primary filter for this leaderboard, the final ranking is influenced by the interplay between momentum and other factors like quality and risk. For instance, ADBE's inclusion at rank 23 with an AIQ Score of 75.0 is supported by its quality score of 91.0, even though its momentum score of 82.0 is lower than that of the top-ranked names.

The overall evidence suggests a landscape where momentum is the primary driver for inclusion, but the specific AIQ Score and rank are determined by the balance of quality and risk. The concentration in Technology remains high, yet the top five positions are currently dominated by Consumer Cyclical and Healthcare names with superior momentum profiles. The significant rank movements of HIG and ACGL indicate that several names are experiencing rapid shifts in their relative standing based on recent momentum data. The exit of several names like V and AMT suggests a shift in the available evidence pool, while new entrants like EXPE and REGN provide fresh data for the current period. Watch whether EXPE maintains its rank 1 position or if the gap between it and ULTA narrows in the next update.